The ultimate goal of NRPB is to strengthen the capability of the midstream function of the biopharmaceutical development pipeline; through the validation of preclinical testing and clinical trials, fulfilling the vision of commercializing scientific outcomes. The short-term goal is to build up and integrate the infrastructures and capabilities for R&D. The mid-term goal is to strengthen IP management and promote industrial bridging. The long-term goal is to train domestic scientists and foster domestic industries for excellence and international competitiveness, and to promote domestic innovations and achievements onto the world stage.